A TYK2 inhibitor in development shows superior efficacy to placebo and apremilast for treating psoriasis, with no new safety ...

Organon recently presented post-hoc pooled Phase 3 ADORING 1 and 2 data showing VTAMA cream achieved early, statistically significant improvements in atopic dermatitis severity and itch versus vehicle ...

71.4% and 69.2% of patients treated with zasocitinib achieved a static Physician Global Assessment (sPGA) score of 0/1 versus placebo (10.7% and 12.6%) and apremilast (32.1% and 29.7%) at week 16 (p<0 ...

Presentations at the 2026 meeting of the American Academy of Dermatology not only demonstrate the therapeutic potential of ...

Doctors say persistent nipple changes can sometimes signal Paget’s disease, a rare condition linked to breast cancer.

CNW/ - Takeda Canada Inc. ("Takeda") is pleased to announce new data from the two pivotal Phase 3 studies of zasocitinib (TAK ...

We talked to allergists and researched products to find the best ways to keep a healthy home. Here are 29 items we recommend.

Know Shirodhara, a calming Ayurvedic therapy that helps reduce stress, improve sleep quality, and promote deep relaxation ...